Sai Life Sciences IPO – Sai Life Sciences, a well-established name in the contract research and manufacturing services (CRAMS) industry, is preparing to launch its Initial Public Offering (IPO). Known for its robust pharmaceutical solutions, the company’s IPO is generating significant interest among investors. Here’s a comprehensive overview:
About Sai Life Sciences Limited
Incorporated in 1999, Sai Life Sciences Limited specializes in researching, developing, and manufacturing small-molecule chemical entities. The company serves over 280 pharmaceutical innovators, including 18 of the top 25 global pharma companies in 2023.
The company offers a range of services:
- Chemistry, manufacturing, and control (CMC)/CDMO.
- Integrated discovery services for biology, chemistry, and drug metabolism.
Key Stats as of September 30, 2024:
- Total employees: 3,135 (including 2,353 scientific staff).
- Clients include leading firms across the US, UK, Europe, and Japan.
Competitive Strengths:
- Integrated CRDMO platform offering end-to-end solutions.
- Collaboration with a mix of commercial and under-development molecules.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
On July 31, 2024, Sai Life Sciences submitted its Draft Red Herring Prospectus (DRHP) to the Securities and Exchange Board of India (SEBI), marking the beginning of its IPO process. Then, on December 6, 2024, the company achieved a key milestone by filing its Red Herring Prospectus (RHP).
Sai Life Sciences IPO Details
| Particulars | Details |
| IPO Date | December 11, 2024, to December 13, 2024 |
| Listing Date | Wednesday, December 18, 2024 |
| Face Value | ₹1 per share |
| Price Band | ₹522 to ₹549 per share |
| Lot Size | 27 shares |
| Total Issue Size | 55,421,123 shares (₹3,042.62 Cr) |
| Fresh Issue | 17,304,189 shares (₹950.00 Cr) |
| Offer for Sale | 38,116,934 shares (₹2,092.62 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Pre-Issue Shareholding | 190,685,340 shares |
| Post-Issue Shareholding | 207,989,529 shares |
Sai Life Sciences IPO Timeline
| Event | Date |
| IPO Open Date | Wednesday, December 11, 2024 |
| IPO Close Date | Friday, December 13, 2024 |
| Basis of Allotment | Monday, December 16, 2024 |
| Initiation of Refunds | Tuesday, December 17, 2024 |
| Credit of Shares | Tuesday, December 17, 2024 |
| Listing Date | Wednesday, December 18, 2024 |
| Cut-off Time for UPI Mandate Confirmation | 5 PM on December 13, 2024 |
Sai Life Sciences IPO Reservation
| Investor Category | Shares Offered |
| Qualified Institutional Buyers (QIB) | Not more than 50% of the Net Issue |
| Retail Investors | Not less than 35% of the Net Issue |
| Non-Institutional Investors (NII) | Not less than 15% of the Net Issue |
Sai Life Sciences IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351.00 | ₹192,699 |
| S-HNI (Min) | 14 | 378.00 | ₹207,522 |
| S-HNI (Max) | 67 | 1,809 | ₹993,141 |
| B-HNI (Min) | 68.00 | 1,836 | ₹1,007,964 |
Sai Life Sciences Promoter Holding
| Promoter Holding | Percentage |
| Pre-Issue | 40.48% |
| Post-Issue | 0.00% |
Sai Life Sciences Financials
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets (₹ Cr) | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 |
| Revenue (₹ Cr) | 693.35 | 1,494.27 | 1,245.11 | 897.74 |
| Profit After Tax (₹ Cr) | 28.01 | 82.81 | 9.99 | 6.23 |
| Net Worth (₹ Cr) | 1,044.75 | 974.34 | 887.29 | 877.76 |
| Reserves (₹ Cr) | 855.69 | 953.99 | 867.43 | 859.17 |
| Borrowings (₹ Cr) | 764.49 | 710.16 | 699.23 | 751.32 |
Key Performance Indicators
| KPI | Values |
| ROE | 11.79% |
| ROCE | 15.96% |
| RoNW | 8.13% |
| P/BV | 10.18 |
| PAT Margin (%) | 5.65% |
Check Out: One Mobikwik Systems IPO Details
Sai Life Sciences Limited Contact Details
| Particulars | Details |
| Address | Plot No. DS-7, IKP Knowledge Park,Turkapally Village, Shameerpet Mandal,Malkajgiri District, Hyderabad-500078 |
| Phone | +91 40 6815 6000 |
| [email protected] | |
| Website | sailife.com |
Sai Life Sciences Limited IPO Registrar
| Particulars | Details |
| Phone | 04067162222, 04079611000 |
| [email protected] | |
| Website | kosmic.kfintech.com/ipostatus |
This easy-to-understand guide covers all the key information about the Sai Life Sciences IPO to help you make an informed decision. For more detailed insights, please refer to the Sai Life Sciences IPO Red Herring Prospectus (RHP).
FAQs
Q.1. What is the IPO open and close date for Sai Life Sciences?
Ans: IPO Open Date: Wednesday, December 11, 2024, IPO Close Date: Friday, December 13, 2024
Q.2. What is the Basis of Allotment date?
Ans: The Basis of Allotment will be announced on Monday, December 16, 2024.
Q.3. When will the refunds be initiated?
Ans: Refunds will be initiated on Tuesday, December 17, 2024.
Q.4. When will the shares be credited to the demat account?
Ans: The credit of shares will take place on Tuesday, December 17, 2024.
Q.5. What is the listing date for the Sai Life Sciences IPO?
Ans: The listing date is Wednesday, December 18, 2024.
Q.6. What is the price band for the Sai Life Sciences IPO?
Ans: The price band is set between ₹522 to ₹549 per share.
Q.7. What is the lot size for the IPO?
Ans: The minimum lot size for the IPO is 27 shares.
Q.8. What is the total issue size for the Sai Life Sciences IPO?
Ans: The total issue size is 55,421,123 shares, amounting to ₹3,042.62 Crore.
Q.9. What is the Fresh Issue size?
Ans: The Fresh Issue consists of 17,304,189 shares, valued at ₹950.00 Crore.
Q.10. What is the Offer for Sale size?
Ans: The Offer for Sale includes 38,116,934 shares, worth ₹2,092.62 Crore.
TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.